CEP-9722 Uses, Dosage, Side Effects and more
CEP-9722 is under investigation in clinical trial NCT01345357 (Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma).
| Trade Name | CEP-9722 |
| Generic | CEP-9722 |
| Type | |
| Formula | C24H26N4O3 |
| Weight | Average: 418.497 Monoisotopic: 418.200490713 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
